Newest generation of leading heart stent is now approved in the U.S. for people with coronary artery disease

A recent press release by Abbott Nutrition announces their recent approval from the U.S FDA for XIENCE Sierra. 

 

Editor's Note: This article originally appeared on Abbott's website

Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for XIENCE SierraTM, the newest generation of the company's gold-standard XIENCE everolimus-eluting coronary stent system. XIENCE stents are among the world's most-used and studied stents and have an exceptional safety record with low rates of complications. Design and technology advances in this generation of XIENCE include features specifically designed for the treatment of complex blockages that now account for up to 70 percent of cases. Click here to continue>>

 

News From Our Partners 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars